| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0016-5085(85)80185-2 |
| P698 | PubMed publication ID | 3964778 |
| P2093 | author name string | B A Hills | |
| J E Richards | |||
| L M Lichtenberger | |||
| P2860 | cites work | Effect of prostaglandin E2 on aspirin-induced gastric mucosal injury | Q39229022 |
| The effect of membrane lipid composition on the permeability of membranes to Ca2+. | Q40093383 | ||
| Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms | Q40108380 | ||
| ION TRANSPORT IN ISOLATED RABBIT ILEUM. I. SHORT-CIRCUIT CURRENT AND NA FLUXES | Q42093223 | ||
| The effects of dexamethasone and prostaglandin F2alpha on production and release of surfactant in type II alveolar cells | Q67028163 | ||
| Molecular species of phosphatidylcholine from rat gastric mucosa | Q67028699 | ||
| Synthesis and metabolism of prostaglandins E2, F2alpha and D2 by the rat gastrointestinal tract. Stimulation by a hypertonic environment in vitro | Q67398906 | ||
| Inhibition of fetal lung maturation by indomethacin in pregnant rabbits | Q67429741 | ||
| Role of surface-active phospholipids in gastric cytoprotection | Q71672962 | ||
| Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach | Q71723035 | ||
| Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate | Q71756584 | ||
| Water repellency induced by pulmonary surfactants | Q71861143 | ||
| P433 | issue | 1 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| prostaglandin E2 | Q416554 | ||
| P304 | page(s) | 308-314 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa | |
| P478 | volume | 88 |
| Q35352637 | Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently. |
| Q42424288 | Asthma: is there an airway receptor barrier? |
| Q47583181 | Effect of enprostil on amphibian gastroduodenal and human gastric bicarbonate secretion |
| Q42010674 | Effect of luminal pH on the output of bicarbonate and PGE2 by the normal human stomach |
| Q67975441 | Effect of sucralfate on components of mucosal barrier produced by cultured canine epithelial cells in vitro |
| Q44129728 | Effects of 16,16-dimethyl prostaglandin E2 on glycoprotein and lipid synthesis of gastric epithelial cells grown in a primary culture |
| Q42133102 | Effects of antiulcer drugs on phosphatidylcholine synthesis in isolated guinea pig gastric glands |
| Q43212856 | Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. |
| Q28190071 | Gastric mucosal integrity: gastric mucosal blood flow and microcirculation. An overview |
| Q70275651 | Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study |
| Q34410436 | Gastric surfactant and the hydrophobic mucosal barrier |
| Q37885723 | Gastrointestinal effects of aspirin |
| Q72313640 | In vitro recovery of canine gastric mucosal surface hydrophobicity and potential difference after aspirin damage |
| Q34517165 | Mechanism of non-steroidal anti-inflammatory drug-gastropathy |
| Q37785035 | Mechanisms of NSAID-induced gastroenteropathy |
| Q28324039 | Mechanisms of gastroduodenal protection by sucralfate |
| Q34375359 | Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism |
| Q39764245 | Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective? |
| Q36526925 | Non-steroidal anti-inflammatory drug associated ulcer: Epidemiology, causation and treatment |
| Q38627221 | Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management |
| Q34377174 | Phospholipid composition of human gastric mucosa: a study of endoscopic biopsy specimens |
| Q39587257 | Physiology and pharmacology of prostaglandins |
| Q38678800 | Prostaglandins in the gut and their relationship to non-steroidal anti-inflammatory drugs |
| Q38596275 | Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins. |
| Q40699124 | Some of the factors that may mediate or modify the gastrointestinal mucosal damage induced by non-steroidal anti-inflammatory drugs |
| Q44131270 | Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. |
| Q42513380 | Surface hydrophobicity and water transport of the toad urinary bladder: effects of vasopressin |
| Q43762685 | The effect of etodolac on bile salt and histamine-mediated gastric mucosal injury in the rat. |
| Q37717322 | The management of NSAID gastropathy |
| Q69900981 | The role of arachidonic acid metabolites in gastrointestinal homeostasis. Biochemical, histological and clinical gastrointestinal effects |
| Q93513487 | Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins |
| Q54061012 | Topical prostaglandin E2 protects isolated gastric mucosa against acidified taurocholate-, but not ethanol- or aspirin-induced injury. |
| Q34584895 | Upper gastrointestinal bleeding: etiology and management |
Search more.